Try our beta test site
51 studies found for:    Northwestern AND Sinus
Show Display Options
Rank Status Study
1 Completed
Has Results
Point-of-Care Computed Tomography (CT) Chronic Rhinosinusitis Study
Condition: Chronic Rhinosinusitis
Interventions: Procedure: Pre-treatment Sinus CT Scan;   Procedure: Post-treatment Sinus CT Scan
2 Recruiting His Bundle Pacing Versus Coronary Sinus Pacing for Cardiac Resynchronization Therapy
Condition: Congestive Heart Failure
Intervention: Device: CRT Pacemaker
3 Recruiting Corticosteroid Therapy for Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
Condition: Chronic Rhinosinusitis Without Nasal Polyps
Interventions: Drug: Prednisone;   Drug: Topical mometasone
4 Active, not recruiting Chronic Rhinosinusitis With or Without Nasal Polyps Steroid Study
Conditions: Chronic Sinusitis;   Rhinosinusitis;   Nasal Polyps
Intervention: Drug: Prednisone
5 Unknown  Effects of Endoscopic Sinus Surgery for Chronic Sinusitis on Asthma Control
Conditions: Asthma;   Chronic Sinusitis
Interventions: Procedure: Endoscopic Sinus Surgery;   Other: medical therapy
6 Completed Clinical Evaluation of Safety and Efficacy of S8 Sinus Implant in Chronic Sinusitis Patients
Conditions: Chronic Sinusitis;   Nasal Polyposis
Interventions: Drug: S8 Sinus Implant;   Drug: Steroid nasal spray
7 Completed Medical Therapy Versus Sinus Surgery for Chronic Rhinosinusitis: A Prospective, Multi-institutional Study
Conditions: Chronic Rhinosinusitis;   Sinusitis
Intervention:
8 Completed
Has Results
Rhythm Evaluation for AntiCoagulaTion With COntinuous Monitoring
Condition: Atrial Fibrillation
Intervention: Drug: Non-coumadin Oral Anticoagulant
9 Enrolling by invitation Anti-Inflammatory Agent in Sinusitis
Condition: Nasal Polyps
Interventions: Drug: AZ compound;   Other: Collection of Biological Specimens;   Drug: Intranasal corticosteroid
10 Unknown  Positive Predictive Value of the Dx-pH Probe for Predicting PPI Response in LPR
Conditions: Laryngopharyngeal Reflux (LPR);   Extraesophageal Reflux;   Reflux Laryngitis;   Posterior Laryngitis
Intervention: Other: Single-center prospective evaluation of the Restech pH probe
11 Enrolling by invitation Tissue-Type Plasminogen Activator (t-PA) Release Predicts Major Adverse Cardiac Events (MACE) in Patients With Non-critical Coronary Artery Disease
Condition: Coronary Artery Disease
Intervention: Drug: Bradykinin
12 Completed
Has Results
Study to Evaluate Safety and Effectiveness of AdvaCoat Sinus Gel
Conditions: Ethmoid Sinusitis;   Rhinosinusitis
Interventions: Device: AdvaCoat sinus gel;   Device: Merogel Injectable
13 Completed
Has Results
A Clinical Evaluation of a Steroid-Coated Sinus Stent When Used Following Functional Endoscopic Sinus Surgery in Patients With Chronic Sinusitis
Condition: Chronic Sinusitis
Interventions: Device: Sinus Stent with drug coating;   Device: Non Coated Sinus Stent
14 Completed Safety and Efficacy of a Steroid-Releasing Sinus Implant for Recurrent Sinus Obstruction
Condition: Chronic Sinusitis
Interventions: Drug: S8 Sinus Implant;   Procedure: Sham procedure
15 Completed Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
Conditions: Head and Neck Cancer;   Lung Cancer
Interventions: Drug: celecoxib;   Procedure: adjuvant therapy
16 Unknown  Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)
Conditions: Cancer of the Pharynx;   Cancer of the Larynx;   Cancer of the Nasal Cavity;   Paranasal Sinus Neoplasms;   Cancer of the Oral Cavity
Interventions: Drug: docetaxel;   Drug: cisplatin;   Drug: hydroxyurea;   Drug: fluorouracil;   Procedure: chemotherapy;   Procedure: radiotherapy
17 Active, not recruiting Safety and Performance Study of the INGEVITY Lead
Conditions: Bradycardia;   Sinus Node Dysfunction
Intervention: Device: INGEVITY lead
18 Completed
Has Results
Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment
Conditions: Asthma;   Atopy
Interventions: Drug: fluticasone;   Drug: Placebo
19 Unknown  Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Drug: fluorouracil;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel;   Radiation: radiation therapy
20 Recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Conditions: Acinar Cell Carcinoma;   Adrenal Cortex Carcinoma;   Adrenal Gland Pheochromocytoma;   Anal Canal Neuroendocrine Carcinoma;   Anal Canal Undifferentiated Carcinoma;   Appendix Mucinous Adenocarcinoma;   Bladder Adenocarcinoma;   Bronchioloalveolar Carcinoma;   Cervical Adenocarcinoma;   Cervical Squamous Cell Carcinoma, Not Otherwise Specified;   Cholangiocarcinoma;   Chordoma;   Colorectal Squamous Cell Carcinoma;   Endometrioid Adenocarcinoma;   Esophageal Neuroendocrine Carcinoma;   Esophageal Undifferentiated Carcinoma;   Extrahepatic Bile Duct Carcinoma;   Fallopian Tube Adenocarcinoma;   Fibromyxoid Tumor;   Gastric Neuroendocrine Carcinoma;   Gastric Squamous Cell Carcinoma;   Giant Cell Carcinoma;   Intestinal Neuroendocrine Carcinoma;   Intrahepatic Cholangiocarcinoma;   Lung Carcinoid Tumor;   Lung Sarcomatoid Carcinoma;   Major Salivary Gland Carcinoma;   Malignant Odontogenic Neoplasm;   Malignant Peripheral Nerve Sheath Tumor;   Malignant Skin Neoplasm;   Malignant Testicular Sex Cord-Stromal Tumor;   Metastatic Malignant Neoplasm of Unknown Primary Origin;   Mixed Mesodermal (Mullerian) Tumor;   Mucinous Adenocarcinoma;   Mucinous Cystadenocarcinoma;   Nasal Cavity Adenocarcinoma;   Nasal Cavity Carcinoma;   Nasopharyngeal Carcinoma;   Nasopharyngeal Papillary Adenocarcinoma;   Nasopharyngeal Undifferentiated Carcinoma;   Oral Cavity Carcinoma;   Oropharyngeal Undifferentiated Carcinoma;   Ovarian Adenocarcinoma;   Ovarian Germ Cell Tumor;   Ovarian Mucinous Adenocarcinoma;   Ovarian Squamous Cell Carcinoma;   Pancreatic Acinar Cell Carcinoma;   Pancreatic Neuroendocrine Carcinoma;   Paraganglioma;   Paranasal Sinus Adenocarcinoma;   Paranasal Sinus Carcinoma;   Parathyroid Gland Carcinoma;   Pituitary Gland Carcinoma;   Placental Choriocarcinoma;   Placental-Site Gestational Trophoblastic Tumor;   Primary Peritoneal High Grade Serous Adenocarcinoma;   Pseudomyxoma Peritonei;   Scrotal Squamous Cell Carcinoma;   Seminal Vesicle Adenocarcinoma;   Seminoma;   Serous Cystadenocarcinoma;   Small Intestinal Adenocarcinoma;   Small Intestinal Squamous Cell Carcinoma;   Spindle Cell Neoplasm;   Squamous Cell Carcinoma of the Penis;   Teratoma With Malignant Transformation;   Testicular Non-Seminomatous Germ Cell Tumor;   Thyroid Gland Carcinoma;   Tracheal Carcinoma;   Transitional Cell Carcinoma;   Undifferentiated Gastric Carcinoma;   Ureter Adenocarcinoma;   Ureter Squamous Cell Carcinoma;   Urethral Adenocarcinoma;   Urethral Squamous Cell Carcinoma;   Vaginal Adenocarcinoma;   Vaginal Squamous Cell Carcinoma, Not Otherwise Specified;   Vulvar Adenocarcinoma;   Vulvar Squamous Cell Carcinoma
Interventions: Procedure: Biospecimen Collection;   Biological: Ipilimumab;   Biological: Nivolumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.